Nearly 60% of US adults qualify for at least one novel cardiovascular, kidney, or metabolic drug — most often a GLP-1 receptor agonist — with many eligible for more than one class of drugs.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/about-60-adults-qualify-heart-renal-or-metabolic-meds-2026a10003yp?src=rss
Author :
Publish date : 2026-02-09 10:37:00
Copyright for syndicated content belongs to the linked Source.
